Nov. 3, 2011 |
| |
|
||||||||
![]() Universities continue to increase startups and commercialization of research The Chronicle of Higher Education Share ![]() ![]() ![]() ![]() Universities' activity in commercializing academic research continued to increase in the 2010 fiscal year, despite the sour economy. Institutions completed more licensing deals with companies than in the previous year while also forming more startup companies and filing for more patents, according to newly released data from the Association of University Technology Managers. More End the patent wars Harvard Business Review Share ![]() ![]() ![]() ![]() The Court of Appeals for the Federal Circuit, the nation's top patent court, recently reached a decision that will have breathtaking ramifications: scientific research methods per se can be patented for a field of research. This decision promises to accelerate the flood of patent litigation, which shows that the recent America Invents Act does not go far enough to fix the patent system. More Robotic eye surgery ready for commercialization MedCity News Share ![]() ![]() ![]() ![]() Robotic eye surgery. A researcher has completed work on a da Vinci-like eye surgery robot that can operate more precisely on the retina and vitreous humour. The surgeon uses joysticks to operate the robot, which can perform quick instrument changes and filter out tremors from the opthamologist. A doctoral candidate at Eindhoven University of Technology in the Netherlands says he plans to commercialize the technology and thinks the first surgery using the robot will be performed on humans within five years. More Wave of interest in new cancer therapy Medical Press Share ![]() ![]() ![]() ![]() The Director of Biotechnology at Victoria University is part of a multidisciplinary team that aims to use viruses and bacteria, or microbes, that cause diseases, such as measles, botulism, gangrene and the common cold, as the basis of new forms of cancer treatment. These microbes will be engineered to make an enzyme that can activate cancer prodrugs — a new generation of therapies that remain inert in the body until activated by the enzymes that Dr Ackerley's group at Victoria are developing. There is growing international interest in prodrugs as an alternative to chemotherapy, because of their ability to kill cancer cells while leaving healthy cells unharmed. More Charleston biotech company to commercialize university's research Charleston Regional Business Journal Share ![]() ![]() ![]() ![]() A Charleston, N.C.-based biotech company has signed a collaborative agreement to license a patent from Georgia State University in Atlanta to commercialize research conducted at the school. VaxyGen Manufacturing Services LLC, which is operating in the SCRA MUSC Innovation Center, has signed an agreement with Georgia State’s Research Foundation to provide VaxyGen the exclusive license to a patent for producing and purifying proteins in development as biopharmaceutical and vaccine products. More Commercializing technology, improving society The News Journal Share ![]() ![]() ![]() ![]() Yushan Yan's new laboratory in Newark, Del., is just starting to show signs of life — vibrancy that state and University of Delaware officials hope will springboard innovation in coming years. Yan is a new engineering professor at the university, and arrived with a 16-person crew: nine early-career scientists and seven eager doctoral candidates. They followed the renowned energy researcher across the country, from the University of California at Riverside. More The robots are coming Engineering on the Edge Share ![]() ![]() ![]() ![]() Mankind has been fascinated by robotics since ancient times when myths told of bronze guardians and the Greek god of blacksmiths, Hephaestus, building mechanical servants. We've come a long way from the clockwork automatons built in Archytas and Lu Ban to the industrial robots common in today's factories. However, we've always fallen short of the sci-fi robots that would help us with our daily tasks ... until now. One robotic challenge is that machines can't "feel" very well. Stanford University researchers have created a thin film pressure sensor that can stretch or compress and measure that force. Created from single-wall carbon nano-tubes, this "artificial skin" could be used on robots to allow them to have a sense akin to touch. More ![]() AUTM Annual Meeting — Schedule now available AUTM Share ![]() ![]() ![]() ![]() Are you new to the AUTM Annual Meeting? Attend the Freshman Orientation and Networking Event on Wednesday, March 14. This event is designed to help you maximize your experience at the AUTM Annual Meeting. #AUTM2012 More AUTM Venture Forum AUTM Share ![]() ![]() ![]() ![]() Friday, March 16 2 p.m. - 4:30 p.m. The AUTM 2012 Venture Forum will provide AUTM attendees the opportunity to hear from and interact with some of the top institutional and corporate venture investors in the country. The Venture Forum will consist principally of two events: the business plan competition and a venture capital panel discussion. More ![]() |
![]()
|
|